期刊
CELL REPORTS
卷 20, 期 11, 页码 2639-2653出版社
CELL PRESS
DOI: 10.1016/j.celrep.2017.08.044
关键词
-
类别
资金
- Radcliffe Department of Medicine/MRC Scholars Programme Studentship
- MRC [G0902418]
- Ovarian Cancer Action [HER00070]
- Oxford Biomedical Research Centre, the National Institute of Health Research [IS-BRC-0211-10025]
- BBSRC [BB/ N006550/1]
- Wellcome Trust ISSF [105605/Z/14/Z]
- BBSRC [BB/N006550/1] Funding Source: UKRI
- MRC [G0902418] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/N006550/1] Funding Source: researchfish
- Medical Research Council [G0902418] Funding Source: researchfish
Synthetic receptors provide a powerful experimental tool for generation of designer cells capable of monitoring the environment, sensing specific input signals, and executing diverse custom response programs. To advance the promise of cellular engineering, we have developed a class of chimeric receptors that integrate a highly programmable and portable nuclease-deficient CRISPR/Cas9 (dCas9) signal transduction module. We demonstrate that the core dCas9 synthetic receptor (dCas9-synR) architecture can be readily adapted to various classes of native ectodomain scaffolds, linking their natural inputs with orthogonal output functions. Importantly, these receptors achieved stringent OFF/ON state transition characteristics, showed agonist-mediated dose-dependent activation, and could be programmed to couple specific disease markers with diverse, therapeutically relevant multi-gene expression circuits. The modular dCas9-synR platform developed here provides a generalizable blueprint for designing next generations of synthetic receptors, which will enable the implementation of highly complex combinatorial functions in cellular engineering.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据